IP Library Granted Patent US 6,441,145
Granted Patent Utility
US 6,441,145 · App. 09/143,155

Transgenically produced Antithrombin III

Inventors: Paul DiTullio, Harry Meade, Edward S. Cole
Patented Case View Patent ↗
Granted: Aug 27, 2002 Filed: Aug 28, 1998
Inventors
Paul DiTullio
Harry Meade
Edward S. Cole
Assignee (at issue)
Genzyme Transegenic Corporation

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,441,145
App. No.
09/143,155
Filed
1998-08-28
Granted
2002-08-27
Kind
B1